Clinical trial
Cutaneous Lupus Erythematosus and Elidel
NCT00222183 · University of Leipzig, Other · Withdrawn
Key facts
| NCT number | NCT00222183 |
|---|---|
| Title | Cutaneous Lupus Erythematosus and Elidel |
| Official title | Evaluation of the Therapeutic Effect and Local Tolerability of Elidel® Cream 1% (Pimecrolimus) in Chronic Discoid Lupus Erythematosus (dLE) or Subacute Cutaneous Lupus Erythematosus (scLE) |
| Lead sponsor | University of Leipzig, Other |
| Collaborators | Novartis Industry |
| Status | Withdrawn |
| Study type | Interventional |
| Conditions | Lupus Erythematosus, Cutaneous, Discoid |
| Intervention type | Drug |
| Interventions | Elidel (pimecrolimus) |
| Enrollment | 0 |
| Start date | Jun 1, 2003 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 28, 2018 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: